69ÀÏʪ»ú¸£Àû

Saturday 21 December 2024
69ÀÏʪ»ú¸£Àû Foundation Trust

FOI_6584

Internal Reference Number: FOI_6584

Date Request Received: 11/05/2022 00:00:00

Date Request Replied To: 24/05/2022 00:00:00

This response was sent via: By Email

Request Summary: Intra-vitreal injections or implants

Request Category: Companies

 
Question Number 1:
I am analysing the usage of intra-vitreal injections or implants by the NHS. I would greatly appreciate if you could answer the following questions:

How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2022:

• Aflibercept

• Bevacizumab

• Brolucizumab

• Dexamethasone

• Fluocinolone acetonide

• Ranibizumab


 
Answer To Question 1:
Aflibercept 1657
Bevacizumab 9
Brolucizumab 0
Dexamethasone 14
Fluocinolone Acetonide <5
Ranibizumab 47
 
Question Number 2:
Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022.


Eye Conditions - Wet Age-Related Macular Degeneration wAMD


Aflibercept

Bevacizumab

Brolucizumab

Dexamethasone

Fluocinolone acetonide

Ranibizumab


 
Answer To Question 2:
Aflibercept 1164
Bevacizumab 6
Brolucizumab 0
Dexamethasone 0
Fluocinolone Acetonide 0
Ranibizumab 43
 
Question Number 3:
Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022.

Eye Condition - Diabetic Macular Degeneration DMO

Aflibercept

Bevacizumab

Brolucizumab

Dexamethasone

Fluocinolone acetonide

Ranibizumab
 
Answer To Question 3:
Aflibercept 190
Bevacizumab 0
Brolucizumab 0
Dexamethasone 9
Fluocinolone Acetonide <5
Ranibizumab 0
 
Question Number 4:
Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022.

Eye Conditions - Retinal Vein Occulusion RVO

Aflibercept

Bevacizumab

Brolucizumab

Dexamethasone

Fluocinolone acetonide

Ranibizumab
 
Answer To Question 4:
Aflibercept 236
Bevacizumab 0
Brolucizumab 0
Dexamethasone <5
Fluocinolone Acetonide 0
Ranibizumab <5
 
To return to the list of all the FOI requests please click here

Our staff at 69ÀÏʪ»ú¸£Àû District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

69ÀÏʪ»ú¸£Àû, 69ÀÏʪ»ú¸£Àû District Hospital, Odstock Road, 69ÀÏʪ»ú¸£Àû, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 69ÀÏʪ»ú¸£Àû
Trust Values